PlainPharmaWatch

CMS Open Payments · Program Year 2024

Human Regenerative Technologies

Human Regenerative Technologies reported $118,750.00 in payments to 60 physicians and teaching hospitals across 61 transactions.

See the rankings → How this is sourced
$118.8K
Total payments
61
Transactions
60
Recipients
+$10.8K
General Payments vs PY2022

Human Regenerative Technologies reported $118,750.00 in payments to 60 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1140 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $2.0K per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Human Regenerative Technologies pairs below-median payment volume with a moderately concentrated payment pattern.

#1140
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
1
payment categories

Release-over-release change

General Payments changed from PY2022 to PY2024

Human Regenerative Technologies's CMS-reported General Payments increased by $10.8K (+19.9%) from PY2022 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: HUMAN REGENERATIVE TECHNOLOGIESPY2024: Human Regenerative Technologies. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2022 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2022$54.0KPY2024$64.8K
PY2022
$54,000.00
PY2024
$64,750.00

How Human Regenerative Technologies ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Human Regenerative Technologies's total vs. every reporting company

CMS Open Payments, Program Year 2024

$118,750 41st percentile higher than 41% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). This entry sits in this band. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Human Regenerative Technologies

In Program Year 2024, Human Regenerative Technologies reported $118,750.00 in payments to 60 physicians and teaching hospitals across 61 individual transactions, an average of $1.9K per transaction and $2.0K per recipient. That total places Human Regenerative Technologies at rank #1140 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Compensation for Services Other Than Consulting" leads the 1-category general-payment breakdown below at $64.8K (54.5% of the company's reported total, 60 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 1 types of general payments, Human Regenerative Technologies's largest category was "Compensation for Services Other Than Consulting" at $64.8K - 54.5% of the company's reported total.

How Human Regenerative Technologies divides its payments

How the reported total splits across payment categories

1. Compensation for Services…$64.8K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $64.8K 60

Recipient Concentration in General Payments

The five largest recipient relationships account for $64,750.00 (100.0%) of $64,750.00 in this company's General Payments records across 5 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Human Regenerative Technologies

The five named recipients with the highest reported General Payments from this company

Kay May Kwok$22.2KSteven Rosenberg$14.7KAlexandra Bujor$11.2KBen Naghi$10.7KFreya Marshall$6.0K
  1. 1

    Kay May Kwok

    $22,200.00 across 12 reported transactions

  2. 2

    Steven Rosenberg

    $14,650.00 across 12 reported transactions

  3. 3

    Alexandra Bujor

    $11,200.00 across 12 reported transactions

  4. 4

    Ben Naghi

    $10,700.00 across 12 reported transactions

  5. 5

    Freya Marshall

    $6,000.00 across 12 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $1.9K. Average per recipient: $2.0K.

Total Amount

$118,750.00

Avg per Transaction

$1.9K

Avg per Recipient

$2.0K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Human Regenerative Technologies Share

0.0%

#1140 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Human Regenerative Technologies

Noctrix Health, Inc.

$118.6K 124 recipients

Forte Bio-Pharma LLC

$118.4K 5,751 recipients

Brainlab, Inc.

$119.2K 382 recipients

Neptune Medical Inc.

$119.4K 49 recipients

Brixton Biosciences, Inc.

$117.6K 72 recipients

Jan Medical Inc.

$117.5K 6 recipients

Frequently Asked Questions

How much did Human Regenerative Technologies pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $118,750.00 from Human Regenerative Technologies to physicians and hospitals across 61 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Human Regenerative Technologies? ▾
Human Regenerative Technologies made payments to 60 physicians and teaching hospitals in 2024. The average payment per recipient was $2.0K.
What types of payments did Human Regenerative Technologies make? ▾
1 categories of general payment make up Human Regenerative Technologies's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Compensation for Services Other Than Consulting" at $64.8K, representing 54.5% of the company's reported total.
How does Human Regenerative Technologies rank among pharmaceutical companies? ▾
Human Regenerative Technologies ranks #1140 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Human Regenerative Technologies? ▾
In 2024, Human Regenerative Technologies averaged $1.9K per transaction across 61 transactions to 60 recipients.
Where does the payment data for Human Regenerative Technologies come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Human Regenerative Technologies's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.